Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001780854-25-000002

Chief Commercial Ofc Imm Med sold 606,402 shares at an average $16.73 ($10,144,026)

  • Chief Commercial Ofc Imm Med acquired 510,470 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BENZENO SHARON · Chief Commercial Ofc Imm Med

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-20 Exercise or conversion : show line 1 in the form 10b5-1 +133,032 $8.46 $1,125,451 525,755 D
2025-11-20 Exercise or conversion : show line 2 in the form 10b5-1 +68,961 $12.14 $837,187 594,716 D
2025-11-20 Sale : show line 3 in the form 10b5-1 −297,925 $16.54 $4,927,680 296,791 D
2025-11-21 Exercise or conversion : show line 4 in the form 10b5-1 +834 $6.27 $5,229 297,625 D
2025-11-21 Exercise or conversion : show line 5 in the form 10b5-1 +20,834 $6.55 $136,463 318,459 D
2025-11-21 Exercise or conversion : show line 6 in the form 10b5-1 +49,480 $6.55 $324,094 367,939 D
2025-11-21 Exercise or conversion : show line 7 in the form 10b5-1 +34,375 $7.27 $249,906 402,314 D
2025-11-21 Exercise or conversion : show line 8 in the form 10b5-1 +119,809 $12.14 $1,454,481 522,123 D
2025-11-21 Exercise or conversion : show line 9 in the form 10b5-1 +83,145 $3.99 $331,749 605,268 D
2025-11-21 Sale : show line 10 in the form 10b5-1 −308,477 $16.91 $5,216,346 296,791 D
Open-market sales · 606,402 sh · avg $16.73 · $10,144,026

Table II: Derivative

8 lines
Date Transaction Shares Owned after D/I
2025-11-20 Exercise or conversion : show line 11 in the form 10b5-1 Stock Option (right to buy) −133,032 66,517 D
2025-11-20 Exercise or conversion : show line 12 in the form 10b5-1 Stock Option (right to buy) −68,961 136,970 D
2025-11-21 Exercise or conversion : show line 13 in the form 10b5-1 Stock Option (right to buy) −834 0 D
2025-11-21 Exercise or conversion : show line 14 in the form 10b5-1 Stock Option (right to buy) −20,834 0 D
2025-11-21 Exercise or conversion : show line 15 in the form 10b5-1 Stock Option (right to buy) −49,480 0 D
2025-11-21 Exercise or conversion : show line 16 in the form 10b5-1 Stock Option (right to buy) −34,375 0 D
2025-11-21 Exercise or conversion : show line 17 in the form 10b5-1 Stock Option (right to buy) −119,809 17,161 D
2025-11-21 Exercise or conversion : show line 18 in the form 10b5-1 Stock Option (right to buy) −83,145 116,404 D
Loading xslF345X05/primary_doc.xml…